xIPOmeter
Element Biosciences
Element Biosciences is a biotechnology firm focused on innovative and cost-effective sequencing technologies. Their flagship AVITI System, a benchtop sequencer, offers high accuracy and low costs with dual independent flow cells and Avidity Base Chemistry (ABC) to minimize common PCR-related errors. The company also offers the AVITI24, combining sequencing and cyto-profiling for detailed cellular analysis, particularly useful in cancer research. Their Cloudbreak kits enhance sequencing efficiency, and the ElemBio Cloud platform aids in real-time monitoring and data visualization.
NewsHeat chart
- Week
- Month
- Year
- Media news
- Corp news
The data in the chart above is based on data derived from our proprietary XP calculation model and may be changed, adjusted and updated without prior notice
Company Valuation
- Valuation
- Share Price
- Cumulative Funding
The data in the tables and charts is based on data from public sources and although we make every effort to compile the data, it may not coincide with the actual data of the issuer.
*** - To view the data, please log into your account or create a new one.
Company valuation calculator
To calculate, specify one of the parameters
News related to Element Biosciences1
Element BiosciencesElement Biosciences Raises Over $277 Million to Develop and Commercialize Differentiated Products and Continue Rapid Growth
This funding will further support the commercialization of AVITI™, Element's benchtop DNA sequencer ...
https://www.prnewswire.com/news-releases/element-biosciences-raises-over-277-million-to-develop-and-commercialize-differentiated-products-and-continue-rapid-growth-302194120.html
Investors6
Wellington Management
Fidelity
Venrock
T. Rowe Price
Alexandria Venture Investments
Meritech Capital Partners